Over the past thirteen consecutive days, YIDU TECH (02158) has repurchased over 61 million Hong Kong dollars. The company has been selected to join the national-level "Revealing the Leader" list in cooperation with Tongji Hospital.

date
20:04 11/02/2026
avatar
GMT Eight
On February 11th, iCarbonX Technology repurchased over 480,000 shares at a price of approximately HK$6 per share, totaling nearly HK$3 million, achieving the thirteenth consecutive day of intensive repurchases.
On February 11th, YIDU TECH (02158) released its latest stock repurchase announcement: the company repurchased over 480,000 shares at a price of approximately HK$6 per share on the same day, with a total investment of nearly HK$3 million. This marks the thirteenth consecutive day of intensive repurchase, with a cumulative repurchase amount exceeding HK$61 million, conveying the company's long-term confidence in its value through consistent and prudent capital actions. At the industry level, AI healthcare is now at a key point in its commercial development. CITIC SEC report states that medical AI will accelerate the restructuring of the trillion-dollar pharmaceutical market. CITIC SEC believes that in 2026, there has been a fundamental change in the logic of AI healthcare, with clearer and stronger payment sources for AI healthcare this year. Therefore, 2026 is expected to be a year with stronger certainty in the commercialization of AI healthcare and an opening up of the space for commercialization. It is recommended to focus on five main themes and related targets: AI pharmaceuticals, primary AI healthcare applications, medical data circulation transactions, AI pathological diagnosis, AI healthcare models, and expansion channels for C-end. In terms of news, YIDU TECH has recently received more positive business news: YIDU TECH and Tongji Hospital affiliated with Tongji Medical College of Huazhong University of Science and Technology have successfully applied for the gastrointestinal tumor diagnosis and treatment multimodal AI database project, which was selected for the National Ministry of Industry and Information Technology's 2025 AI medical device innovation task "Champion List". It is reported that the "Champion List" by the Ministry of Industry and Information Technology is a major innovation mechanism established by the country to accelerate the key core technology breakthroughs and promote the transformation of scientific and technological achievements.